Unlike common nutraceuticals stocked in every health store, CJC-1295 is distributed via a dedicated online market that Isumi residents access almost entirely online. This matters because CJC-1295 quality varies dramatically across the market — from analytically confirmed high-purity product to products with serious contamination — and the vendor determines everything about the product. Separating properly characterised CJC-1295 from the rest of the market depends on three things: an HPLC chromatogram documenting ≥98% purity, mass spec data confirming the correct molecular weight, and a batch-specific endotoxin panel. What follows is a sourcing and quality evaluation guide built specifically around CJC-1295, covering everything a Isumi researcher needs to evaluate quality systematically.
Understanding CJC-1295 — Biology & Evidence
CJC-1295 belongs to the growth hormone secretagogue (GHS) class, compounds that stimulate pulsatile growth hormone release by acting on the ghrelin receptor (GHSR-1a) or growth hormone releasing hormone (GHRH) receptor. Ipamorelin, GHRP-2, GHRP-6, and Hexarelin all work primarily through GHSR-1a agonism, producing GH pulses with varying specificity profiles. CJC-1295 and Sermorelin work through the GHRH receptor, mimicking the natural hypothalamic signal for GH release. The downstream effect in both cases is increased pulsatile GH secretion and subsequent IGF-1 production in the liver. For researchers in Isumi studying the GH-IGF-1 axis, this mechanistic clarity makes the GHS class a productive experimental tool.
Where to Buy CJC-1295 — A Researcher's Guide
The first step for any Isumi researcher sourcing CJC-1295 is locating suppliers that experienced researchers actively recommend — commercial rankings reflect SEO budgets rather than product quality. Endotoxin testing in the COA is critical for any injectable research use — endotoxins from bacterial cell wall components can trigger serious immune reactions even at very low concentrations. The combination of peer feedback and direct document verification is the most effective quality filter — community feedback surfaces patterns individual COA review misses, and vice versa. Price is an ineffective primary criterion for CJC-1295 quality — research-grade synthesis and testing has genuine production costs that cannot be cut without consequences, so significantly below-market pricing signals compromises.
Order CJC-1295 — ships to Isumi
COA-verified · International tracking · Research grade
As a research compound, CJC-1295 has not completed the clinical trial process required for pharmaceutical approval — its safety profile is characterised by preclinical data and limited human studies. Temperature excursions — even temporary temperature deviation — can cause partial degradation without visible changes; always maintain cold chain and work with cold-shipped material. Endotoxin testing in the CJC-1295 COA is not optional — gram-negative bacterial endotoxins can trigger dangerous immune responses at very low concentrations, and no pricing advantage justifies skipping this verification. For any individual considering CJC-1295 outside a formal research context: seek medical advice first — this compound is unapproved for human therapeutic application and its safety characterisation does not match that of regulated drugs.
Frequently Asked Questions
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
